PYPL
41
2
RIG
60
5
OI
28
3
GLW
48
-4
VNO
52
-8
EMC
62
6
EQT
30
-9
HES
62
4
LNC
39
-6
UA
39
3
CCI
28
3
VZ
32
-2
ABBV
57
-2
PDCO
38
2
AMGN
47
8
NOV
52
3
MDT
59
-3
KEY
33
-4
ROK
38
-14
SLG
62
3
PYPL
41
2
RIG
60
5
OI
28
3
GLW
48
-4
VNO
52
-8
EMC
62
6
EQT
30
-9
HES
62
4
LNC
39
-6
UA
39
3
CCI
28
3
VZ
32
-2
ABBV
57
-2
PDCO
38
2
AMGN
47
8
NOV
52
3
MDT
59
-3
KEY
33
-4
ROK
38
-14
SLG
62
3
Financhill
Back

Pieris Pharmaceuticals Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
45

PIRS
Pieris Pharmaceuticals

Last Price:
16.95
Seasonality Move:
9.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Pieris Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Pieris Pharmaceuticals has on average historically risen by 9.2% based on the past 9 years of stock performance.
  • Pieris Pharmaceuticals has risen higher in 2 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 22.22%
  • Is Pieris Pharmaceuticals Stock Undervalued?
    The current Pieris Pharmaceuticals [PIRS] share price is $16.98. The Score for PIRS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • PIRS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Pieris Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Pieris Pharmaceuticals has on average historically risen by 9.2% based on the past 9 years of stock performance.

Pieris Pharmaceuticals Stock Rating

Sell
45
Pieris Pharmaceuticals (PIRS) is a Sell

Is Pieris Pharmaceuticals overpriced?

  • Pieris Pharmaceuticals has risen higher in 2 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 22.22%

Pieris Pharmaceuticals Stock Price History

Is PIRS stock going to rise?

  • The current trend is moderately bullish and PIRS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
pieris.com

52-Week Data

52-Week High:
23.20
52-Week Low:
6.20

Prediction Charts

Market Cap:
22.42M
Price in USD:
16.98
Volume:
18.58K
Beta:
0.78

Technical Analysis

SMA50:
16.89
SMA100:
14.54
SMA200:
13.65
52-Wk Change:
-18.54%

Stock Predictions

  • Is Pieris Pharmaceuticals stock public?
    Yes, Pieris Pharmaceuticals is a publicly traded company.
  • What is the Pieris Pharmaceuticals stock quote today?
    The Pieris Pharmaceuticals stock price is 16.98 USD today.
  • How to buy Pieris Pharmaceuticals stock online?
    You can buy Pieris Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 16.36 16.49 16.50 16.23
Oct-17 16.71 16.93 16.96 16.52
Oct-18 16.85 16.92 16.92 16.85
Oct-21 16.91 16.80 16.91 16.66
Oct-22 16.63 16.42 16.83 16.35
Oct-23 16.50 16.95 16.95 16.38
Oct-24 16.55 17.00 17.00 16.55
Oct-25 16.51 16.94 16.99 16.51
Oct-28 16.75 17.00 17.00 16.70
Oct-29 17.00 17.00 17.20 17.00
Oct-30 16.90 16.87 16.90 16.51
Oct-31 17.00 16.98 17.33 16.72
Nov-1 17.25 17.30 17.47 17.10
Nov-4 17.21 16.98 17.35 16.97

Pieris Pharmaceuticals Earnings

Pieris Pharmaceuticals Earnings Report: Per Share Pieris Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Pieris Pharmaceuticals Forecast Revenue Growth

Pieris Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Pieris Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.

* Pieris Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.